annual EBITDA:
-$285.40M-$112.56M(-65.13%)Summary
- As of today (September 16, 2025), AKRO annual EBITDA is -$285.40 million, with the most recent change of -$112.56 million (-65.13%) on December 31, 2024.
- During the last 3 years, AKRO annual EBITDA has fallen by -$184.76 million (-183.58%).
- AKRO annual EBITDA is now -6153.40% below its all-time high of -$4.56 million, reached on December 31, 2017.
Performance
AKRO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$80.87M+$9000.00(+0.01%)Summary
- As of today (September 16, 2025), AKRO quarterly EBITDA is -$80.87 million, with the most recent change of +$9000.00 (+0.01%) on June 30, 2025.
- Over the past year, AKRO quarterly EBITDA has dropped by -$15.13 million (-23.02%).
- AKRO quarterly EBITDA is now -19109.74% below its all-time high of -$421.00 thousand, reached on March 31, 2018.
Performance
AKRO quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$321.47M-$15.13M(-4.94%)Summary
- As of today (September 16, 2025), AKRO TTM EBITDA is -$321.47 million, with the most recent change of -$15.13 million (-4.94%) on June 30, 2025.
- Over the past year, AKRO TTM EBITDA has dropped by -$87.29 million (-37.28%).
- AKRO TTM EBITDA is now -58884.77% below its all-time high of -$545.00 thousand, reached on December 1, 2017.
Performance
AKRO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AKRO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.1% | -23.0% | -37.3% |
| 3 y3 years | -183.6% | -193.8% | -191.8% |
| 5 y5 years | -525.5% | -393.1% | -425.0% |
AKRO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -183.6% | at low | -219.0% | +1.0% | -191.8% | at low |
| 5 y | 5-year | -525.5% | at low | -436.8% | +1.0% | -425.0% | at low |
| alltime | all time | -6153.4% | at low | <-9999.0% | +1.0% | <-9999.0% | at low |
AKRO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$80.87M(-0.0%) | -$321.47M(+4.9%) |
| Mar 2025 | - | -$80.88M(+3.7%) | -$306.33M(+7.3%) |
| Dec 2024 | -$285.40M(+65.1%) | -$78.01M(-4.5%) | -$285.40M(+6.0%) |
| Sep 2024 | - | -$81.70M(+24.3%) | -$269.27M(+15.0%) |
| Jun 2024 | - | -$65.74M(+9.7%) | -$234.17M(+14.8%) |
| Mar 2024 | - | -$59.95M(-3.1%) | -$203.99M(+18.1%) |
| Dec 2023 | -$172.84M(+50.4%) | -$61.87M(+32.7%) | -$172.73M(+26.8%) |
| Sep 2023 | - | -$46.61M(+31.1%) | -$136.21M(+8.4%) |
| Jun 2023 | - | -$35.56M(+24.0%) | -$125.63M(+6.8%) |
| Mar 2023 | - | -$28.68M(+13.1%) | -$117.59M(+2.3%) |
| Dec 2022 | -$114.90M(+14.2%) | -$25.36M(-29.6%) | -$114.90M(-5.8%) |
| Sep 2022 | - | -$36.02M(+30.9%) | -$121.92M(+10.6%) |
| Jun 2022 | - | -$27.53M(+5.9%) | -$110.19M(-1.2%) |
| Mar 2022 | - | -$25.99M(-19.7%) | -$111.56M(+10.9%) |
| Dec 2021 | -$100.64M | -$32.38M(+33.3%) | -$100.64M(+2.7%) |
| Sep 2021 | - | -$24.29M(-16.0%) | -$97.99M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$28.91M(+91.8%) | -$95.19M(+15.1%) |
| Mar 2021 | - | -$15.07M(-49.3%) | -$82.68M(+3.4%) |
| Dec 2020 | -$79.94M(+75.2%) | -$29.72M(+38.3%) | -$79.94M(+20.4%) |
| Sep 2020 | - | -$21.49M(+31.0%) | -$66.42M(+8.5%) |
| Jun 2020 | - | -$16.40M(+33.1%) | -$61.23M(+16.8%) |
| Mar 2020 | - | -$12.32M(-23.9%) | -$52.44M(+14.9%) |
| Dec 2019 | -$45.63M(+231.2%) | -$16.20M(-0.7%) | -$45.63M(+40.8%) |
| Sep 2019 | - | -$16.31M(+114.3%) | -$32.40M(+81.8%) |
| Jun 2019 | - | -$7.61M(+38.0%) | -$17.82M(-5.6%) |
| Mar 2019 | - | -$5.51M(+85.7%) | -$18.87M(+37.0%) |
| Dec 2018 | -$13.78M(+201.9%) | -$2.97M(+71.9%) | -$13.78M(+21.3%) |
| Sep 2018 | - | -$1.73M(-80.1%) | -$11.36M(+17.9%) |
| Jun 2018 | - | -$8.66M(+1957.5%) | -$9.63M(+896.7%) |
| Mar 2018 | - | -$421.00K(-22.8%) | -$966.00K(+77.2%) |
| Dec 2017 | -$4.56M | - | - |
| Dec 2017 | - | -$545.00K | -$545.00K |
FAQ
- What is Akero Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Akero Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Akero Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Akero Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of AKRO is -$285.40M
What is the all time high annual EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual EBITDA is -$4.56M
What is Akero Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, AKRO annual EBITDA has changed by -$112.56M (-65.13%)
What is Akero Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of AKRO is -$80.87M
What is the all time high quarterly EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly EBITDA is -$421.00K
What is Akero Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, AKRO quarterly EBITDA has changed by -$15.13M (-23.02%)
What is Akero Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of AKRO is -$321.47M
What is the all time high TTM EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM EBITDA is -$545.00K
What is Akero Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, AKRO TTM EBITDA has changed by -$87.29M (-37.28%)